Improvement of glucose and lipid metabolism with pegylated interferon-α plus ribavirin therapy in Chinese patients chronically infected with genotype 1b hepatitis C virus

Author:

Qing Shao1,Ji Dong12,Li Bing1,Li Fan1,Wang Yudong3,Niu Xioaxia1,Ling Binfang4,Meng Yuhua4,Lau George3,Chen Guofeng1

Affiliation:

1. Liver Cirrhosis Diagnosis and Treatment Second Center, 302 Military Hospital of China, Beijing, China

2. Liver FailureTreatment and Research Center, 302 Military Hospital of China, Beijing, China

3. Division of Gastroenterology & Hepatology, Humanity & Health Medical Centre, Hong Kong, Hong Kong SAR, China

4. Nursing Department, 302 Military Hospital of China, Beijing, China

Funder

Chinese Medical Association Clinical Medicine

Publisher

King Faisal Specialist Hospital and Research Centre

Subject

General Medicine

Reference14 articles.

1. Hepatitis C: prevalence, transmission, screening, and prevention[J];Metts J1;FP Essent,2014

2. Assessment of outcomes of hepatitis C treatment[J];Chavez-Tapia NC;JAMA,2014

3. Role of insulin resistance and hepatic steatosis in the progression of fibrosis and response to treatment in hepatitis C[J];Sanyal AJ;Liver Int,2011

4. Impact of Fibroscan on management of chronic viral hepatitis in clinical practice[J];Fransen VDPD;Ann Hepatol,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3